republic-os/legislation/us/states/nj/217/s-2024.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.	Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.	us/states/nj	New Jersey Legislature	217	S 2024	New Jersey S 2024 (217)	bill	DRUG ABUSE REGULATORY	enacted	Benson, Daniel R. Conaway, Herb Eustace, Tim Madden, Fred H. McKnight, Angela V. Mukherji, Raj Oroho, Steven V. Peterson, Erik	1	8	4	2016-04-18T04:00:00+00:00	2016-12-05T05:00:00+00:00	openstates	ocd-bill/6dfb4f83-bee1-420e-8239-492ee6909bda	http://www.njleg.state.nj.us/downloads.asp	65b2df3604ee3a4d1b2b15e03152d72bfe223bf969a6522e021bb5faaf74d9ee	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-nj

New Jersey S 2024 (217) — Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Introduced Version (committee substitute) — source

Votes

• 3RDG FINAL PASSAGE — 73–0 (pass) · legislature
• 3RDG FINAL PASSAGE — 40–0 (pass) · legislature
• Reported favorably out of committee — 11–0 (pass) · legislature
• Reported favorably out of committee — 9–0 (pass) · legislature

Sponsors

• Benson, Daniel R. — primary (person)
• Conaway, Herb — primary (person)
• Eustace, Tim — primary (person)
• Madden, Fred H. — primary (person)
• McKnight, Angela V. — primary (person)
• Mukherji, Raj — primary (person)
• Oroho, Steven V. — primary (person)
• Peterson, Erik — primary (person)
• O'Scanlon, Declan J. — cosponsor (person)
• Pinkin, Nancy J. — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2016-04-18T04:00:00+00:00 Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee introduction, referral-committee
• 2016-05-16T04:00:00+00:00 Reported out of Senate Committee, 2nd Reading committee-passage
• 2016-06-30T04:00:00+00:00 Passed Senate (40-0) passage
• 2016-06-30T04:00:00+00:00 Received in the Assembly, Referred to Assembly Health and Senior Services Committee referral-committee
• 2016-10-06T04:00:00+00:00 Reported out of Assembly Committee, 2nd Reading committee-passage
• 2016-10-20T04:00:00+00:00 Substituted for A3793
• 2016-10-20T04:00:00+00:00 Passed Assembly (Passed Both Houses) (73-0-0) passage
• 2016-12-05T05:00:00+00:00 Approved P.L.2016, c.73. executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/6dfb4f83-bee1-420e-8239-492ee6909bda. Confidence: reported (aggregated from official New Jersey legislature records).